Top compounds associated with response to C12orf42


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.094 0.01
mRNA ML239 CTRPv2 pan-cancer AAC 0.09 0.01
mRNA MP470 GDSC1000 pan-cancer AAC 0.089 0.01
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.079 0.01
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.088 0.01
mRNA OSI-027 CTRPv2 pan-cancer AAC -0.088 0.01
mRNA PX-12 CTRPv2 pan-cancer AAC 0.07 0.01
mRNA BRD-K09587429 CTRPv2 pan-cancer AAC 0.098 0.01
mRNA SB-431542 CTRPv2 pan-cancer AAC 0.092 0.01
mRNA fulvestrant CTRPv2 pan-cancer AAC 0.18 0.01
Download CSV